An Open Label, Randomized, Repeat Dose, 3 Period Crossover Study to Determine the Bioequivalence of 3 Different Formulations of Tamsulosin at Steady State in Healthy Male Volunteers
Latest Information Update: 26 Aug 2023
Price :
$35 *
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Urination disorders
- Focus Pharmacokinetics
- Sponsors GSK
- 27 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Apr 2008 Status changed from initiated to in progress, as reported in ClinicalTrials.gov.
- 08 Mar 2008 New trial record.